Hound Labs, creator of the Hound Cannabis Breathalyzer, entered into an agreement with Quest Diagnostics (NYSE: DGX), a provider of diagnostic information services. The agreement establishes Quest as the exclusive provider of laboratory services for confirmatory testing of positive breath sample results generated by the Hound Cannabis Breathalyzer, used by employers on location as an objective measure to detect and deter cannabis use during the workday.

The Hound Cannabis Breathalyzer, identifies cannabis used within hours of testing and automatically processes results on-location within minutes. Negative test results indicate an employee is not likely to have used cannabis immediately preceding or during the workday. Under the terms, Quest Diagnostics will use a novel mass spectrometry technique it …

Full story available on Benzinga.com